Frequency of Average Scores | P | Total No. Patients | |||||
---|---|---|---|---|---|---|---|

0 | <1.5 | ≥1.5 | |||||

Smad3 | 0.031* | ||||||

Benign | 0 | 4 | 16 | 1.0 (benign versus borderline) | 20 | ||

Borderline | 0 | 6 | 24 | 0.0099 (borderline versus carcinoma) | 30 | ||

Cystadenocarcinoma | 0 | 20 | 19 | 0.0257 (benign versus carcinoma) | 39 | ||

N-Cadherin | 0.996* | ||||||

Benign | 2 | 12 | 5 | 0.0669 (benign versus borderline) | 19 | ||

Borderline | 5 | 24 | 1 | 0.773 (borderline versus carcinoma) | 30 | ||

Cystadenocarcinoma | 14 | 22 | 4 | 0.0319 (benign versus carcinoma) | 40 |

NOTE: Pairwise contrast (logistic regression) between tissue categories are comparing (

*a*) Smad3 average scores of <1.5 versus average scores of ≥1.5 and (*b*) N-cadherin average scores of 0 versus average scores of ≥1.5.↵* Cox proportional hazards regression analysis using Smad3 or N-cadherin as a continuous variable.